Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-01

FDA Approved: DATSCAN — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)

View source ↗

Summary

FDA approved a supplemental application for DATSCAN (ioflupane I-123) by Medi-Physics Inc. dba GE Healthcare.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DaTscan (ioflupane)

Snippet

SUPPL AP for DATSCAN (IOFLUPANE I-123)